Acacia Communications, Inc. (ACIA) Is At $45.08 Formed Wedge, AC Immune SA (ACIU) Sellers Decreased By 8.34% Their Shorts

June 19, 2017 - By Darrin Black

AC Immune SA (NASDAQ:ACIU) had a decrease of 8.34% in short interest. ACIU’s SI was 755,700 shares in June as released by FINRA. Its down 8.34% from 824,500 shares previously. With 59,400 avg volume, 13 days are for AC Immune SA (NASDAQ:ACIU)’s short sellers to cover ACIU’s short positions. The SI to AC Immune SA’s float is 3.51%. The stock decreased 3.62% or $0.32 on June 16, reaching $8.51. About shares traded. AC Immune Ltd (NASDAQ:ACIU) has 0.00% since June 19, 2016 and is . It has underperformed by 16.70% the S&P500.

Acacia Communications, Inc. (ACIA) formed wedge down with $42.83 target or 5.00% below today’s $45.08 share price. Acacia Communications, Inc. (ACIA) has $1.77B valuation. The stock increased 1.39% or $0.62 on June 16, reaching $45.08. About shares traded. Acacia Communications, Inc. (NASDAQ:ACIA) has risen 55.67% since June 19, 2016 and is uptrending. It has outperformed by 38.97% the S&P500.

Among 5 analysts covering Acacia Communications (NASDAQ:ACIA), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Acacia Communications has $125 highest and $39 lowest target. $85.50’s average target is 89.66% above currents $45.08 stock price. Acacia Communications had 9 analyst reports since June 7, 2016 according to SRatingsIntel. The rating was initiated by Needham on Tuesday, June 7 with “Buy”. The firm has “Buy” rating by Deutsche Bank given on Tuesday, June 7. The firm has “Neutral” rating by Goldman Sachs given on Tuesday, June 7. The stock of Acacia Communications, Inc. (NASDAQ:ACIA) has “Equal-Weight” rating given on Thursday, December 8 by Morgan Stanley. Needham maintained the shares of ACIA in report on Friday, August 12 with “Buy” rating. Cowen & Co initiated Acacia Communications, Inc. (NASDAQ:ACIA) rating on Tuesday, June 7. Cowen & Co has “Outperform” rating and $53 target. Deutsche Bank maintained the shares of ACIA in report on Thursday, July 14 with “Buy” rating. Needham maintained Acacia Communications, Inc. (NASDAQ:ACIA) rating on Tuesday, October 11. Needham has “Buy” rating and $125 target. The stock has “Buy” rating by Deutsche Bank on Friday, September 9.

AC Immune Ltd is a Switzerland-based firm engaged in the medical biotechnology sector. The company has market cap of $466.30 million. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson’s, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology platforms. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: